ArticleKidney medicine2025

EPO-Mimetic Peptide Pegmolesatide Therapy for Pure Red Cell Aplasia in a Patient with Non-dialysis-dependent Type 1 Diabetic Nephropathy: A Case Report.

Qiong Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.